Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SNS-032
i
Other names:
SNS-032, BMS-387032
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Viracta Therap
Drug class:
CDK inhibitor
Related drugs:
‹
MK-7965 (4)
PHA 793887 (1)
AT7519 (0)
R-547 (0)
RGB-286638 (0)
E7070 (0)
P27600 (0)
BAY1000394 (0)
MK-7965 (4)
PHA 793887 (1)
AT7519 (0)
R-547 (0)
RGB-286638 (0)
E7070 (0)
P27600 (0)
BAY1000394 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
CDK9 overexpression
Uveal Melanoma
CDK9 overexpression
Uveal Melanoma
SNS-032
Sensitive: D – Preclinical
SNS-032
Sensitive
:
D
SNS-032
Sensitive: D – Preclinical
SNS-032
Sensitive
:
D
CDK7 overexpression
Uveal Melanoma
CDK7 overexpression
Uveal Melanoma
SNS-032
Sensitive: D – Preclinical
SNS-032
Sensitive
:
D
SNS-032
Sensitive: D – Preclinical
SNS-032
Sensitive
:
D
CCNE1 overexpression
Ovarian Cancer
CCNE1 overexpression
Ovarian Cancer
SNS-032
Sensitive: D – Preclinical
SNS-032
Sensitive
:
D
SNS-032
Sensitive: D – Preclinical
SNS-032
Sensitive
:
D
CCNE1 amplification
Ovarian Cancer
CCNE1 amplification
Ovarian Cancer
SNS-032
Sensitive: D – Preclinical
SNS-032
Sensitive
:
D
SNS-032
Sensitive: D – Preclinical
SNS-032
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login